WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (97)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levine, M. S.
Right arrow Articles by Westphal, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levine, M. S.
Right arrow Articles by Westphal, H.

 Previous Article  |  Next Article 

Volume 16, Number 18, Issue of September 15, 1996 pp. 5870-5882
Copyright ©1996 Society for Neuroscience

Modulatory Actions of Dopamine on NMDA Receptor-Mediated Responses Are Reduced in D1A-Deficient Mutant Mice

Michael S. Levine1, Katharine L. Altemus1, Carlos Cepeda1, Howard C. Cromwell1, Cynthia Crawford1, Marjorie A. Ariano2, John Drago3, David R. Sibley4, and Heiner Westphal5

1 Mental Retardation Research Center, University of California, Los Angeles, Los Angeles, California 90024-1759, 2 Department of Neuroscience, The Chicago Medical School, North Chicago, Illinois 60064, 3 Anatomy Department, Monash University, Clayton, Victoria 3168, Australia, 4 Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland 20892, and 5 Laboratory of Mammalian Genes and Development, National Institutes of Child Health and Human Development, Bethesda, Maryland 20892

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

The role of D1 dopamine (DA) receptors in mediating the ability of DA to modulate responses attributable to activation of NMDA receptors was examined in mice lacking D1A dopamine receptors. Specifically, experiments were designed to test the hypothesis that the ability of DA to potentiate responses mediated by activation of NMDA receptors was attributable to activation of D1 receptors. Based on this hypothesis, we would predict that in the D1A mutant mouse, either DA would not induce enhancement of NMDA-mediated responses, or the enhancement would be severely attenuated. The results provided evidence to support the hypothesis. In mutant mice, DA and D1 receptor agonists did not potentiate responses mediated by activation of NMDA receptors. In contrast, in control mice, both DA and D1 receptor agonists markedly potentiated responses mediated by activation of NMDA receptors. The effects of DA in attenuating responses mediated by activation of non-NMDA receptors also were altered in the mutant, suggesting that this action of DA may require coupling or interactions between D1 and D2 receptors. The present studies also provided an opportunity to assess some of the basic electrophysiological and morphological properties of neostriatal neurons in mice lacking D1A DA receptors. Resting membrane potential, action potential parameters, input resistance, excitability, somatic size, dendritic extent, and estimates of spine density in mutants and controls were similar, suggesting that these basic neurophysiological and structural properties have not been changed by the loss of the D1A DA receptor.

Key words: dopamine receptors; D1; excitatory amino acid receptors; knock-out mice; mutant; neostriatal slices; NMDA

INTRODUCTION

There is considerable interest in understanding the functional interactions between dopamine (DA) and excitatory amino acid (EAA) neurotransmission in the neostriatum. It is well known that EAAs and DA have many potential sites for physiological interactions in the neostriatum and that a close morphological association exists between the glutamate-containing and DA-containing inputs (Bouyer et al., 1984; Freund et al., 1984; Smith and Bolam, 1990). The glutamate-containing inputs make synaptic contacts on the heads of spines, whereas the DA-containing inputs synapse on spine necks, dendritic shafts, and cell bodies (Smith and Bolam, 1990; Seasack et al., 1994).

We have studied some of the factors involved in determining how DA and EAAs interact in the neostriatum and neocortex (Cepeda et al., 1992b, 1993; Levine et al., 1995, 1996; Altemus and Levine, 1996). We have primarily examined the hypothesis that the combination of subtypes of EAA and DA receptors activated determines the direction of subsequent DA modulation. We recently reported that DA potentiates responses mediated by activation of NMDA receptors, but attenuates responses mediated by activation of non-NMDA receptors in neocortex (Cepeda et al., 1992b) and neostriatum (Cepeda et al., 1993; Levine et al., 1995, 1996). The effects of DA on responses mediated by NMDA receptor activation were mimicked by application of a D1 receptor agonist and were blocked by a D1 antagonist, whereas the effects of DA on responses mediated by non-NMDA receptor activation were mimicked by application of a D2 receptor agonist.

The recent development of DA receptor gene-targeted mutant mice lacking specific receptor subtypes offers additional opportunities to test hypotheses concerning functional interactions among DA and EAA receptors. Mutant mice lacking D1A, D2, and D3 DA receptors have been generated (Drago et al., 1994; Xu et al., 1994a,b, 1995; Balk et al., 1995; Accili et al., 1996). Although the D2 mutant has been reported to be cataleptic (Balk et al., 1995), mice lacking D1A or D3 receptors appear hyperactive (Xu et al., 1994a,b; Miner et al., 1995; Accili et al., 1996) or display behavioral changes such as a marked lack of rearing (Drago et al., 1994). The present experiments were designed to use the D1A mutant to further examine the hypothesis that DA-induced enhancement of responses mediated by activation of NMDA receptors in the neostriatum is attributable to activation of D1 receptors. We would predict that in the D1A mutant, DA would not induce enhancement of NMDA-mediated responses, or that enhancement would be severely attenuated. The present studies also provide an opportunity to assess some of the basic electrophysiological and morphological properties of neostriatal neurons in mice lacking D1A DA receptors.

MATERIALS AND METHODS

Animals All procedures were performed in accordance with the U.S. Public Health Service Guide for Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the University of California, Los Angeles (UCLA). Mice with a targeted inactivated D1A DA receptor gene were obtained from a breeding colony established at the National Institutes of Health (NIH) (Drago et al., 1994). Initially, homozygous (-/-) mice and littermate controls (+/+) were obtained and used in experiments until a parallel breeding colony was established at UCLA. Data from all but 12 animals were obtained from the UCLA colony. There were no consistent differences in results obtained from the UCLA and the NIH colony, and data were pooled.

All animals were housed under standard conditions on a 12 hr light/dark cycle with food and water available ad libitum. Experiments were performed on both male and female controls (+/+) and homozygous mutant mice (-/-) littermates of at least 80 d of age. Heterozygous mice were not studied. Multiple experiments were performed on tissue obtained from the same animal by different experimenters on the same day. Typically, experiments were performed on two animals per week, one control and one mutant. To avoid experimenter bias, brain slices were prepared by an individual who did not perform the experiment, and experimenters were not informed of the genotype of the animal until data had been obtained from both animals for each week. The order of experiments performed on mutant or control mice also was randomized for each week.

Genotyping mice D1A receptor knock-out mice were generated from embryonic stem cells in which one of the D1A receptor alleles was targeted in vitro by homologous recombination (Drago et al., 1994). Briefly, a targeting construct was designed (pKO.3) in which a neomycin phosphotransferase gene was inserted into a region of the D1A receptor gene encoding the fifth transmembrane domain. In addition, 0.75 kb of gene sequence downstream of the insertion site was excised. The excised sequence encodes the third intracytoplasmic loop, the removal of which generates an inactive gene product. Positive clones were used to create chimeric mice. Chimeric males were mated with female C57BL/6 mice to create heterozygotes. Southern analysis was used to identify the genotype of mice (Drago et al., 1994). D1A mRNA and protein detection To verify morphologically the altered expression of D1A receptors in the neostriatum, receptor transcript and protein were assessed in tissue slices (10 µm) from mutant (n = 3) and control (n = 3) mice. For these analyses, brains were prepared at UCLA, coded, and then shipped to the Chicago Medical School for analysis of mRNA and protein. Decoding was performed after morphological experiments were complete. For mRNA, a primer of 39 mer and ~50% GC content was synthesized (NBI, Plymouth, MN) for the D1A DA receptor. The primer used, 5'-GGACATCTTAAAGGAACTTTCAGACTGGGCGCATTCGAC-3', corresponded to a portion of the carboxyl tail and bases 1424-1463 on the sense strand of the transcript (Monsma et al., 1990). In situ transcription followed the protocol described previously (Noblett and Ariano, 1996). Sections were hybridized to the primer overnight, followed by enzymatic extension using reverse transcriptase (Seikagaku, Rockville, MD). Rhodamine-labeled dUTP (Fluorored, Amersham, Arlington Heights, IL) was incorporated into the nascent cDNA/mRNA heteroduplex to detect transcript expression using routine epifluorescence microscopy. The D1A DA receptor protein was identified using well-characterized antisera (obtained from RBI, Natick, MA) (Levey et al., 1993; Ariano and Sibley, 1994). Standard immunofluorescent methods were used, and primary anti-receptor antisera were incubated overnight, diluted in PBS, pH 7.2, at 1:1000, detected using Bodipy- or fluorescein-labeled secondary antisera (Molecular Probes, Eugene, OR, or Jackson ImmunoResearch, West Grove, PA). The sections were examined using routine epifluorescence microscopy. The validity of in situ transcription was determined by (1) using oligo-d(T)36, which was annealed to all poly(A+)-tailed mRNA in cells undergoing protein synthesis as a positive control, and (2) demonstrating that omission of reverse transcriptase, fluorescent dUTP, or primer produced a complete loss of signal. Slice preparation Mice were killed for rapid brain extraction, the brains were blocked, and rostral tissue containing the neostriatum was sectioned coronally (~350 µm thick). Throughout sectioning, slices were bathed in an oxygenated (95% O2/5% CO2), low-Ca2+, artificial CSF (ACSF) composed of (in m): NaCl 130, KCl 3, NaH2PO4 1.25, MgCl2 5, NaHCO3 26, CaCl2 1, glucose 10. Slices were incubated in lactated bicarbonate ACSF [same as above, except containing (in m): CaCl2 2, MgCl2 2, lactate 4] at 33°C for at least 1 hr before being placed in a Haas-type recording chamber. Intracellular recording In the recording chamber, slices were superfused (1.4 ml/min) with standard ACSF (concentrations in m: NaCl 124, KCl 5, NaH2PO4 1.25, MgSO4 2, NaHCO3 26, CaCl2 2, glucose 10) or Mg2+-free ACSF containing 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (5 µ) to block non-NMDA receptors. Slices were perfused for a minimum of 30 min within the chamber before electrophysiological recording began. This time period was sufficient to produce blockade of responses mediated by non-NMDA receptors (Levine et al., 1996). Glass micropipettes filled with 3 K-acetate (60-200 MOmega ) were used for recording. Signals were amplified (Axoclamp-2A, Axon Instruments, Foster City, CA), displayed on an oscilloscope, and digitized for subsequent computer analysis (pClamp 6.0.1, Axon Instruments). After a neuron was impaled, a baseline recording (20-30 min) was obtained to ensure stability of membrane properties. Only data obtained from neurons with resting membrane potentials of at least -60 mV and action potentials exceeding 55 mV (measured from the start of the rapid rising phase to the peak of the depolarization) were used. All data were obtained from well-impaled neurons in which recordings were made for 1-2 hr. Membrane properties [membrane potential, rheobase (current necessary to elicit an action potential), and input resistance] and action potential characteristics (amplitude and duration at one-half amplitude) were measured during the baseline recording period. Current-voltage relationships were obtained by injection of depolarizing and hyperpolarizing pulses and the cell's input resistance was determined from hyperpolarizing pulses in the linear portion of the current-voltage plots. Evoking responses mediated by activation of EAA receptor subtypes Two methods were used for evoking responses mediated by activation of NMDA receptors. The first method consisted of iontophoretically applying NMDA in the vicinity of the recorded cell in slices bathed in standard ACSF. The second method used local extracellular electrical stimulation to evoke synaptic responses in slices bathed in Mg2+-free ACSF (to remove the voltage-dependent Mg2+ block of the NMDA receptor channel) and CNQX (to block non-NMDA receptor activation). In this condition, locally evoked depolarizing synaptic responses (DPSPs) in the neostriatum are mediated primarily by activation of NMDA receptors (Cherubini et al., 1988; Nisenbaum et al., 1993; Levine et al., 1996). DPSPs also were evoked in slices bathed in standard ACSF. In this condition, responses are mediated primarily by non-NMDA receptors (Herrling, 1985; Cherubini et al., 1988; Nisenbaum et al., 1993; Levine et al., 1996). We verified these findings in the present population of mice by blocking DPSPs in standard ACSF with CNQX (5 µ) and in Mg2+-free ACSF with application of both CNQX (5 µ) and 2-amino-5-phosphonovalerate (25 µ) [an NMDA receptor antagonist (data not shown)].

Iontophoresis. The procedures for iontophoresis in the neostriatal slice have been described (Cepeda et al., 1991a, 1993, 1994, 1996). Briefly, NMDA and DA were applied iontophoretically using a multibarreled micropipette positioned close (100-200 µm) to the recording electrode with the aid of an optical grid. Pipettes contained NMDA (0.1 , pH 8), DA (0.2 , pH 4.5), and saline for current balancing and control. Holding currents of appropriate polarity were 15-20 nA. NMDA was iontophoretically ejected in an ascending series of current intensities until a threshold for inducing action potentials was obtained. Ejection pulse duration varied from 5-15 sec, but was held constant for each cell. The interval between ejection pulses was at least 2 min to avoid cumulative effects of the drugs. Hyperpolarizing current pulses (0.2-0.5 nA, 50-200 msec duration, 0.5 or 1 per sec) were applied through the recording electrode to estimate conductance changes during drug application. Applications of saline (of similar polarity and of equal or greater amplitude than those required to produce effects with NMDA or with DA) never produced effects on membrane or action potentials in the recorded cells (data not shown). In iontophoretic experiments, the effects of DA were measured in standard ACSF. To test the effects of DA or D1 agonists, a single NMDA ejection intensity was chosen (usually near the threshold for inducing action potentials). After a stable baseline response was obtained (2-3 applications of NMDA), DA (applied iontophoretically) or a D1 receptor agonist (SKF 38393, 10-20 µ bath application or A-77636, 3 µ bath application) was applied. Responses to iontophoretically applied NMDA were reassessed after application of DA or the D1 agonist ceased. Three measures were recorded: maximum response amplitude, response duration at half-maximum amplitude, and response area (amplitude × half-amplitude duration). Area was used as a response measure, because subpopulations of cells displayed changes in amplitude or duration but not in both measures and, thus, the area measurement incorporated information from both measures (Levine et al., 1996).

Evoked synaptic responses. The stimulating electrode used to evoke DPSPs consisted of a pair of 0.1 mm diameter Teflon-coated silver wires (exposed 0.25 mm at the tips, tips separated by 0.25 mm) placed ~1-3 mm from the recording electrode. One lead was placed in the corpus callosum and the other lead in the dorsal neostriatum or neocortex. Stimuli consisted of constant current 100 µsec square wave pulses of varying amplitudes (60-2000 µA). Stimulus frequency was 1 pulse/4-5 sec. The stimulation intensity used to elicit DPSPs was ~50-70% of the spike-eliciting intensity. DPSP amplitudes were measured from the start of the rising phase to the peak of the depolarization, whereas durations were measured at half-maximum amplitude. Measurements of amplitudes and durations at half-maximum amplitude were obtained from averages of 4-6 responses. In addition to measuring peak amplitude and duration at half amplitude, DPSP area was computed as described above (amplitude X half-amplitude duration). Measurements were obtained before (baseline), during, and after 15 min exposure to bath-applied DA (20 µ) or the D1 agonist SKF 38393 (5-20 µ). Cells were bathed either in standard ACSF or prebathed in Mg2+-free ACSF containing CNQX (5 µ). DPSPs reached stable amplitudes and durations after 30 min in Mg2+-free ACSF with CNQX.

Concentrations for DA and SKF 38393 were chosen based on previous work in producing potentiation of responses mediated by activation of NMDA receptors in rat neostriatum (Levine et al., 1996). In our experience, 20 µ DA is a midrange concentration that produces an average 30% increase in response amplitude and duration and an average 70% increase in response area. Concentrations for SKF 38393 (5-20 µ) also were based on previous work in the rat (Cepeda et al., 1993; Levine et al., 1996). Concentrations of 10-20 µ produced significant increases in response area in almost all rat neostriatal cells. Concentrations of A-77636 (3 µ) were based on the literature (Kebabian et al., 1992; Acquas et al., 1994). Although we used various concentrations of agonists, we did not attempt to examine systematically concentration-response relationships between cells or within the same cell (e.g., by performing cumulative response studies).

Cell identification In some experiments, electrodes were filled with 2% biocytin (Sigma, St. Louis, MO) in 3 K-acetate to label cells intracellularly for subsequent identification. Cells were labeled to identify the type of neostriatal neuron and to determine whether there were gross morphological differences between cells from mutants and controls. Biocytin was injected with hyperpolarizing current pulses (0.5 Hz, 0.3-0.6 nA). After the experiment, the slice was fixed in 4% paraformaldehyde overnight, then processed according to published protocols (Horikawa and Armstrong, 1988). Measurements of the three longest dendrites for each labeled neuron (from soma to tip) were obtained using a computer-assisted image analysis system (Micromeasure, Analytical Measuring Concepts, Irvine, CA) to estimate the approximate size of the dendritic field. Only dendrites that were entirely in the plane of the section were measured. In addition, measurements of somatic cross-sectional area and long- and short-axis diameters were obtained for each filled neuron. Although spines were not counted, qualitative estimates of their density were obtained by using four categories: 0 = none, 1 = sparse, 2 = medium density, and 3 = abundant and dense. Data quantification and statistics To compare data between cells and across experimental conditions, differences in amplitudes, durations, and areas of responses in the presence of DA or D1 agonists were converted to percentage change from baseline. For bath-applied D1 agonists, quantitative determinations of percentage changes were based on data obtained at the 10 µ concentration, even though some cells were tested with multiple concentrations. There were no differences in changes when NMDA-mediated responses were evoked iontophoretically or synaptically. Thus, for these quantitative analyses, percent change data from each of these techniques were combined.

Statistical analyses were performed on both mean and median values for each group. Medians were analyzed because on inspection of distributions of quantitative changes (Fig. 6), it was apparent that marked distributional shifts were occurring. Differences between mean values for experimental and control conditions were assessed with appropriate t tests. Differences between medians were assessed with Mann-Whitney Rank Sum tests. In the text and tables, values are presented as means ± SE or medians ± interquartile ranges. Differences between means and medians for experimental and control conditions were considered statistically significant when p < 0.05.

Fig. 6. Distributions of percentage change in response area. A, Top two graphs show distributions of changes in response area for all cells from controls and mutants that were exposed to D1 agonists under conditions activating NMDA receptors. Response area of almost all cells in controls increased after exposure to D1 agonists. In contrast, in mutants, changes distributed around zero. B, Bottom two graphs show distributions of changes in response area for all cells from controls and mutants that were exposed to DA. Response area of almost all cells in controls increased after exposure to DA. In contrast, in mutants, there was a wide distribution with a large proportion of cells decreasing in response area. For all graphs, vertical axes are the percentages of cells falling into each category. Horizontal axes are the percentage changes in response area. Note that both increases and decreases in response area are shown.
[View Larger Version of this Image (18K GIF file)]

RESULTS

Genotyping, D1A mRNA, and protein detection

Southern analysis distinguished controls [controls (D1A +/+, a single 4.8 Kb band representing the normal allele), mutant (D1A -/-, a 5.8 Kb band representing the targeted allele), and heterozygotes (D1A +/-, 4.8 and 5.8 Kb)] (Fig. 1). In morphological experiments, the D1A DA receptor mRNA was expressed robustly in control neostriatal neurons (Fig. 2A), whereas the transcripts were completely absent in the mutants (Fig. 2B). Additionally, the encoded protein was easily detected in the control neostriatum (Fig. 2C), but absent in the mutant (Fig. 2D). When the monoclonal rat antisera (Levey et al., 1993) was used for visualization, spurious cross-recognition of blood vessels by the secondary anti-rat antisera occurred in the tissue (Fig. 2C,D, arrowheads). The polyclonal anti-D1A DA receptor antisera (Ariano and Sibley, 1994) showed loss of cell body immunofluorescent protein staining in the mutants as compared with the controls (data not shown).
Fig. 1. Examples of Southern analyses revealing expected patterns of genotypes from tail-derived DNA from six mice. HindIII digests were probed with probe B (Drago et al., 1994). Left lanes are from two mutants (-/-) (5.8 kb), middle lanes are from two heterozygotes (+/-) (4.8 and 5.8 kb), and right lanes are from two controls (+/+) (4.8 kb).
[View Larger Version of this Image (112K GIF file)]

Fig. 2. Morphological assessment of D1A receptor expression in 10-µm-thick tissue sections in mutant and control neostriatum. All photomicrographs were enlarged and printed using identical parameters so that direct comparisons between controls and mutants can be made. A, Transcript for the receptor in the control animal was detected using fluorescent in situ transcription as described in Materials and Methods. Numerous medium-size neurons express robust levels of mRNA for the receptor (arrows). Asterisk indicates myelinated fiber bundles. B, Transcript for the receptor is absent in the mutant neostriatum. C, Receptor protein staining was present as an intense fluorescence within the neuropil, but was excluded from the somata of medium-size cells (arrow) using the commercial rat monoclonal antibody. The corpus callosum (top) is devoid of immunofluorescence, as are the myelinated fiber bundles that course through the neostriatum (asterisk). Arrowhead points to an immunoreactive blood vessel that is an artifact produced by recognition by the secondary-conjugated goat anti-rat antisera. These appeared in sections from both controls and mutants. D, Immunofluorescence for the receptor protein is absent in the mutant animal. The reactive elements are blood vessels (arrowhead).
[View Larger Version of this Image (153K GIF file)]

Electrophysiology

Membrane properties and DPSPs Electrophysiological data were obtained from a total of 92 neurons from mutants and 76 neurons from their control littermates. In general, there were few significant differences in the basic electrophysiological properties between the two groups. Average resting membrane potentials, average action potential amplitudes and half-amplitude durations, and average rheobases were similar in standard ACSF and Mg2+-free ACSF containing CNQX (Fig. 3; Table 1A). Although average input resistances were similar in standard ACSF, in Mg2+-free ACSF containing CNQX, average input resistances were significantly elevated in mutant mice (Table 1A).
Fig. 3. Examples of basic membrane properties. Top traces () show responses to 500 msec depolarizing current pulses capable of generating trains of action potentials in a cell from a control and a cell from a mutant. Middle traces (-) show voltage responses to a series of hyperpolarizing and depolarizing current pulses in the same cells. Bottom graph shows the current-voltage plots derived from the traces. Input resistances (33.8 and 29.5 MOmega for the mutant and control cells, respectively) were calculated from the linear portion of the curves in the hyperpolarizing direction. Resting membrane potentials were -73 mV for the control cell and -72 mV for the mutant cell.
[View Larger Version of this Image (22K GIF file)]

Table 1. Basic membrane and DPSP properties

A. Basic membrane properties

Resting membrane potential (mV) Action potential
 Rheobase (nA) Input resistance (MOmega )
Amplitude (mV) Duration (msec) Standard ACSF Mg2+-free ACSF + CNQX
Control  -73.6  ± 1.2a 72.4  ± 1.1 0.90  ± 0.03 0.58  ± 0.05 30.5  ± 1.4 35.9  ± 3.3b
Mutant  -73.6  ± 1.0 71.4  ± 0.9 0.98  ± 0.04 0.54  ± 0.06 34.6  ± 2.3 47.1  ± 4.1
a Mean ± SE. Values for resting membrane potential, action potential parameters, and rheobase were derived from 49 cells from controls and 55 cells from mutants. Data from cells bathed in standard ACSF and Mg2+-free ACSF + CNQX were pooled, because there were no significant differences between groups. Input resistance measures in standard ACSF were obtained from 16 control and 17 mutant cells and in Mg2+-free ACSF + CNQX from 13 control and 11 mutant cells.
b Difference between means from controls and mutants is statistically significant (t = 2.15, df = 22, p = 0.0431).

B. DPSP amplitude, duration, and area

Amplitude (mV) Standard ACSF duration (msec) Area
Control 12.6  ± 1.1 (n  = 28)a 12.1  ± 0.7 149  ± 13b
Mutant 14.6  ± 0.9 (n  = 29) 13.9  ± 1.1 189  ± 13
Mg2+-free ACSF + CNQX
Control 11.5  ± 1.3 (n  = 21) 39.0  ± 3.6 494  ± 96
Mutant 11.7  ± 1.3 (n  = 21) 49.4  ± 4.3 652  ± 118
a Mean ± SE. Number for each group is in parentheses.
b Difference between means for mutants and controls is statistically significantl (t = -2.11, df = 55, p = 0.0396).

DPSP amplitudes, half-amplitude durations, and areas also were compared in standard and Mg2+-free ACSF containing CNQX. In standard ACSF, only the area of the DPSP was significantly larger in mutant mice compared with controls (Table 1B). When bathed in Mg2+-free ACSF containing CNQX, the duration of the DPSP and its area increased in controls and mutants compared with baseline values obtained for each group in standard ACSF. In Mg2+-free ACSF with CNQX, although both the half-amplitude durations and the areas of the DPSPs were larger in the mutants compared with controls, the differences between groups were not statistically significant. There were no consistent or significant differences in the ranges of electrical stimulation currents or iontophoretic currents necessary to evoke DPSPs between groups or in different bath solutions (data not shown).

Effects of D1 agonists The effects of D1 agonists on mutant and control cells were evaluated in experiments using iontophoretic application of NMDA or in experiments in which DPSPs were mediated primarily by activation of NMDA receptors (Mg2+-free ACSF containing CNQX).

In control mice, bath application of D1 agonists produced consistent and marked increases in responses induced by iontophoretic application of NMDA (Fig. 4). Bath application of SKF 38393 or A-77636 produced increases in amplitude and duration of the depolarization and in action potential frequency in all cells tested. In contrast, the effects of D1 agonists on iontophoretic responses induced by NMDA in mutant cells were markedly reduced (Fig. 4). As expected, based on our previous work in rats (Levine et al., 1996), in control mice, SKF 38393 increased the size of DPSPs mediated by activation of NMDA receptors (Fig. 5). However, in mutants, DPSPs mediated by NMDA receptors (Mg2+-free ACSF + CNQX) were not altered consistently by bath application of SKF 38393. At concentrations of 10 µ, SKF 38393 produced robust increases in the size of DPSPs in control cells (Fig. 5), but minimal increases in mutant cells. Even at higher concentrations of SKF 38393 (20 µ), when increases were induced in mutant cells, they were small (Fig. 5).

Fig. 4. Effects of D1 agonists on responses induced by iontophoretic application of NMDA. A, Effects of SKF 38393. Left column shows a cell from a control mouse. Top trace is baseline response to NMDA alone. Bottom trace shows the potentiation of the response in the presence of bath application of SKF 38393. Right column shows a cell from a mutant. Top trace shows a small depolarizing response to NMDA alone. Bottom trace shows that this response was not altered in the presence of SKF 38393. In this and other figures, iontophoretic current is applied between the arrows, and the numbers next to or below the arrows are the iontophoretic current polarity and intensity. Downward deflections are voltage responses to hyperpolarizing current pulses. Calibrations refer to each column. B, Effects of A-77636. Left column shows a cell from a control mouse. Top trace is baseline response to NMDA alone. Bottom trace shows the potentiation of the response in the presence of bath application of A-77636. Action potentials have been truncated for illustrative purposes. Right column shows a cell from a mutant. Top trace shows a depolarizing response to NMDA alone. Bottom trace shows that this response was not altered in the presence of A-77636. Calibration refers to all traces in B.
[View Larger Version of this Image (26K GIF file)]

Fig. 5. Examples of effects of SKF 38393 on DPSPs. All cells were bathed in Mg2+-free ACSF containing CNQX (5 µ) to evoke DPSPs mediated by activation of NMDA receptors. Top two sets of traces show DPSPs obtained from two cells from controls. Left traces are baseline responses. Right traces show potentiation of responses in the presence of SKF 38393. Bottom two sets of traces are from two cells obtained from mutants. Left traces are baseline responses. Middle traces show minimal potentiation at 10 µ SKF 38393. Right traces show that minimal potentiation also occurred when the concentration of SKF 38393 was increased to 20 µ. All traces are averages of four to six responses. Local electrical stimulation is applied at the arrow. Calibration refers to all traces.
[View Larger Version of this Image (17K GIF file)]

As pointed out in Materials and Methods, because there were no differences in the effects of D1 agonists when responses were induced by iontophoretic application of NMDA or evoked synaptically, data (measures of percent change from baseline obtained from iontophoretic evoked depolarizations and from evoked DPSPs) were pooled for quantitative analysis. In controls, percentage increases in response amplitude, half-amplitude duration, and area were statistically significant compared with baseline conditions (t = 3.01, df = 12, p = 0.0109 for amplitude; t = 6.48, df = 12, p = 0.0074 for half-amplitude duration; t = 3.43, df = 12, p = 0.005 for area) (Table 2 A). In mutants, changes induced by D1 agonists from baseline conditions in amplitude, half-amplitude duration, and area were not statistically significant (Table 2A). Comparisons between controls and mutants in both mean and median changes in response parameters were statistically significant (Table 2A,B). For all mean comparisons and for median comparisons of amplitude and area, the effects of D1 agonists were significantly attenuated for mutants relative to controls.

Table 2. Modulation of responses mediated by activation of NMDA receptors

A. Mean percentage change

D1 agonist
 DA
Amplitude Duration Area Amplitude Duration Area
Control 39  ± 14 (n  = 13)a 22  ± 7 72  ± 21 83  ± 18 (n  = 23) 37  ± 12 149  ± 29
Mutant  -2  ± 3 (n = 19)b 5  ± 4b 5  ± 5b 25  ± 13 (n  = 21)b  -2  ± 4b 23  ± 19b
a Mean + SE. Number for each group is in parentheses. Values are percentage change with respect to baseline. Data in A and B are pooled for responses evoked by iontophoretic application of NMDA and from DPSPs.
b Differences between mean values for D1 agonists and DA for controls and mutants are statistically significant (D1 agonists: t = 3.5, df = 30, p = 0.0015 for amplitude; t = 2.40, df = 31, p = 0.0226 for duration; t = 3.69, df = 30, p = 0.0009 for area; DA: t = 2.52, df = 40, p = 0.0155 for amplitude; t = 3.00, df = 40, p = 0.0047 for duration; t = 3.43, df = 40, p = 0.0014 for area).

B. Median percentage change

D1 agonist
 DA
Amplitude Duration Area Amplitude Duration Area
Control 27 (12 -75)a 17 (0 -38) 66 (11 -119) 64 (23 -100) 14 (6 -44) 115 (58 -181)
Mutant 0 (-9 to 9) 0 (0 -15) 3 (-3 to 19)b 0 (-19 to 26)b 2 (-12 to 6)b 0 (-19 to 26)b
a Median percentage change. Interquartile range in parentheses. Numbers are the same as in A.
b Differences between medians for controls and mutants are statistically significant (Mann-Whitney tests; for D1 agonists p = 0.00354 for amplitude, p = 0.00644 for area; for DA p < 0.0001 for amplitude, p < 0.0001 for duration, p = 0.0030 for area).

To further examine changes in the population of cells, distributions of percentage change in response area were constructed from pooled data from experiments assessing D1 agonist effects on iontophoretic responses and on DPSPs mediated by activation of NMDA receptors (Fig. 6). In controls, most responses (84%, 11/13) were increased in area in the presence of SKF 38393 or A-77636, and 68% (9/13) of the cells displayed increases > 20%. In contrast, the distribution of percentage change in response area in mutant cells appeared to cluster around zero. In mutants, 48% (9/19) of the cells displayed changes in area between ± 10%, whereas 31% (6/19) displayed decreases in area > 10%. Only 21% (4/19) of the cells displayed increases > 20%.

The effects of SKF 38393 also were assessed on DPSPs evoked in standard ACSF (Table 3). In this bath solution, it has been demonstrated that the DPSP is mediated primarily by activation of non-NMDA receptors, because it can be blocked almost completely by application of CNQX (Nisenbaum et al., 1993; Levine et al., 1996). In standard ACSF, SKF 38393 did not have consistent or statistically significant effects on the evoked DPSP obtained from cells from mutants or controls (Table 3). Both increases [40% (2/5) in controls, 64% (7/11) in mutants] and decreases [60% (3/5) in controls, 36% (4/11) in mutants] occurred, and there was little net percentage change (Table 3).

Table 3. Modulation of DPSPs in standard ACSF

A. Mean percentage change

D1 agonist
 DA
Amplitude Duration Area Amplitude Duration Area
Control 5  ± 9 (n  = 6)a 1  ± 10 8  ± 17  -23  ± 6 (n = 12)  -13  ± 6  -31  ± 8
Mutant 6  ± 5 (n  = 11) 3  ± 6 11  ± 9  -12  ± 12 (n  = 12) 14  ± 14  -8  ± 11
a Mean ± SE. Number for each group is in parentheses. Numbers are percentage changes with respect to baseline.

B. Median percentage change

D1 agonist
 DA
Amplitude Duration Area Amplitude Duration Area
Control 6 (-7 to 14)a  -7 (-10 to -2) 1 (-14 to 22)  -19 (-34 to -13)  -9 (-29 to 1)  -30 (-47 to -4)
Mutant 6 (-4 to 21)  -2 (-7 to 23) 10 (-13 to 18)  -14 (-31 to 2)  -2 (-7 to 19)  -13 (-36 to 22)
a Median percentage change. Interquartile range in parentheses. n is the same as in A.

Effects of DA The effects of DA also were evaluated in experiments using iontophoretic application of NMDA and experiments in which DPSPs were mediated by activation of NMDA receptors.

In control mice, DA markedly potentiated responses induced by iontophoretic application of NMDA (Fig. 7) and increased the size of DPSPs mediated by activation of NMDA receptors (Fig. 8). In contrast in mutants, DA did not consistently alter responses induced by iontophoretic application of NMDA (Fig. 7) or DPSPs mediated by NMDA receptor activation (Fig. 8).

Fig. 7. Example of effects of DA on responses induced by iontophoretic application of NMDA. Left and middle columns show cells from controls. Top traces are baseline responses to NMDA alone. Middle traces show the potentiation of the responses in the presence of iontophoretic application of DA. In all columns, DA was applied for 1 min before and during NMDA. Bottom traces show wash 4 min after DA application ceased. Right column shows a cell from a mutant. Top trace shows a depolarizing response to NMDA alone. Middle trace shows that this response was minimally altered in the presence of DA. Bottom trace shows wash 4 min after application of DA. Calibration at left refers to left column. Calibration at right refers to middle and right columns.
[View Larger Version of this Image (23K GIF file)]

Fig. 8. Examples of effects of DA on DPSPs. All cells were bathed in Mg2+-free ACSF containing CNQX (5 µ) to evoke DPSPs mediated by activation of NMDA receptors. Top trace shows DPSPs obtained from a control cell. Left trace is baseline response. Right trace shows potentiation of the response in the presence of DA. Bottom traces are from a mutant cell. Left trace is baseline. Right trace shows that potentiation did not occur in the presence of DA. All traces are averages of four to six responses. Local electrical stimulation is applied at the arrow. Calibration refers to all traces.
[View Larger Version of this Image (10K GIF file)]

Again, data were pooled for quantitative analysis, because there were no differences in percentage changes in response parameters between both methods of evoking NMDA-induced responses. In the presence of DA in controls, amplitudes, durations, and areas of responses significantly increased compared with control conditions (t = 4.32, df = 22, p = 0.0003 for amplitude; t = 3.66, df = 22, p = 0.0014 for duration; t = 2.98, df = 22, p = 0.0069 for area). DA did not significantly alter mean or median amplitudes, durations, or areas in mutants compared with control conditions (Table 2A,B). Comparisons between controls and mutants in both mean and median changes in response parameters were statistically significant. The differences between controls and mutants in amplitude, half-amplitude duration, and area were all statistically significantly (Table 2A,B). Examination of the distributions of changes in response area revealed that although responses evoked in control animals were consistently enhanced by DA (96%, 22/23), responses evoked in mutants were more variably affected (Fig. 6). In mutants, DA decreased 54% (10/19) of the responses and enhanced ~25% (5/19) of the responses by > 20%. Approximately 10% (2/19) of the responses in mutants displayed large increases in the presence of DA (>150% increase in area).

In standard ACSF in cells from controls, DA produced statistically significant decreases in mean response amplitude, duration, and area (t = 4.29, df = 11, p = 0.0013 for amplitude; t = 2.26, df = 11, p = 0.0453 for half-amplitude duration; t = 3.16, df = 11, p = 0.0091 for area) (Table 3). Most (75%, 8/12) of the cells displayed decreases in area by > 20%, one cell decreased between 0 and 20%, and the remaining cells (3/12) displayed increases in area between 0 and 20%. In mutants, the alterations in responses induced by DA were more variable than those produced in controls. The mean changes in response amplitude, duration, and area were not statistically significant compared with baseline conditions for mutants. Although mutants and controls did not differ significantly on any of the measures in standard ACSF, only 30% (3/10) of the mutant cells displayed decreases in response area > 20%, and 40% (4/10) displayed decreases between 0 and 20%. The remainder (3/10) showed increases of > 20%.

Neuronal identification

A total of 58 neurons were labeled (27 from mutants and 31 from controls). All but one cell had the appearance of medium-size spiny neurons. There were no marked qualitative or quantitative differences between cells from mutants and controls (Fig. 9, Table 4). Average somatic cross-sectional area and short- and long-axis diameters were similar (Table 4). There were no significant differences in dendritic length or in the estimate for dendritic spine density (Table 4). In both groups, a small sample of neurons were dye-coupled [15% (4/27 recovered cells in mutants) and 13% (4/31) in controls].
Fig. 9. Photomicrographs of biocytin-filled cells. The top shows a control cell at two magnifications. The bottom shows a cell from a mutant at two magnifications. The dendrites of the cells from both the control and the mutant mice were covered with spines.
[View Larger Version of this Image (148K GIF file)]

Table 4. Measurements from biocytin-filled cells

Control Mutant
Somatic cross-section area (µm2) 145  ± 10a 132  ± 12
Somatic long axis diameter (µm) 16.9  ± 0.7 15.9  ± 0.8
Somatic short axis diameter (µm) 13.0  ± 0.6 12.9  ± 0.8
Average dendrite length (µm)b 150  ± 5.5 143  ± 4.6
Spine densityc 1.21  ± 0.2 1.24  ± 0.3
a Mean ± SE; n = 31 for controls and n = 27 for mutants.
b Average of the length of three dendrites for each cell.
c Average of the rating scores for each cell. See text for explanation of ratings for spine density.

DISCUSSION

The present experiments had two purposes. The first was to use the D1A DA receptor-deficient mutant to examine the hypothesis that DA-induced enhancement of responses mediated by activation of neostriatal NMDA receptors is attributable to activation of D1 DA receptors. The second was to assess basic electrophysiological and morphological properties of neostriatal neurons in mice lacking D1A DA receptors.

DA modulation of NMDA responses

Based on our previous findings (Cepeda et al., 1993; Levine et al., 1996), we would predict that either DA would not enhance NMDA-mediated responses or that the enhancement would be severely attenuated in the mutant. The results provide evidence to support this hypothesis. When responses were mediated by activation of NMDA receptors in mutants, DA had minimal effects. Furthermore, agonist activation of D1 receptors also had little net effect on responses mediated by NMDA receptors. These outcomes suggested that there was minimal compensation for this function of D1A receptors by D1B DA or serotonin receptors in the mutant. However, it should be pointed out that a small population of cells in the mutant displayed large increases in NMDA receptor-mediated response to DA or D1 agonists. It is possible that this population expresses D1B receptors (Carter-Russell et al., 1995).

Previously, we have demonstrated that DA and D1 agonists enhanced responses mediated by activation of NMDA receptors in rat neostriatum, cat caudate nucleus, human caudate nucleus, and human neocortex (Cepeda et al., 1992b, 1993, 1994). The present studies demonstrated that similar enhancement occurs in the control mouse, indicating that DA/NMDA receptor interactions in the neostriatum are distributed widely across species. In contrast, there is diversity in how DA modulation of EAA transmission is expressed in different neural areas. DA enhances non-NMDA receptor-mediated responses via D1 receptors and the cAMP/PKA transduction cascade in cultured chick spinal cord motoneurons (Smith et al., 1995), in goldfish Mauthner cells (Pereda et al., 1992, 1994), and in the retina (Knapp et al., 1990). In the hippocampus, DA, via D1 receptor activation, induces a long-lasting synaptic potentiation (Huang and Kandel, 1995) involving both NMDA and non-NMDA receptors (Frey et al., 1993; Huang and Kandel, 1995). DA reduces excitatory synaptic transmission in nucleus accumbens by activating presynaptic D1 DA receptors (Higashi et al., 1989; Pennartz et al., 1992; Nicola et al., 1996). In the neocortex, DA and D1 activation decreases both non-NMDA and NMDA-mediated synaptic transmission (Law-Tho et al., 1994). It would appear then, that the actions of DA are expressed differently depending on the area and, possibly, the type of neuron studied.

Synaptic responses evoked in vivo by cortical stimulation and synaptic responses evoked by local stimulation in vitro in neostriatal slices bathed in standard ACSF have been shown to be mediated primarily by activation of non-NMDA glutamate receptors (Herrling, 1985; Cherubini et al., 1988; Nisenbaum et al., 1993; Levine et al., 1996). DA typically decreases the size of these responses in a concentration-dependent manner (Herrling and Hull, 1980; Mercuri et al., 1985; Levine et al., 1996). The present experiments demonstrated that this decrease occurred in the control mouse. However, the mutant showed considerable variability in this action of DA. We have demonstrated that the attenuation by DA of non-NMDA receptor-mediated responses may involve D2 receptors, because it is mimicked by quinpirole, a D2 receptor agonist, and blocked by domperidone, a D2 receptor-specific antagonist (Levine et al., 1996). It is presently unclear why responses that may be mediated by D2 receptors are altered potentially in the mutant. Although we did not test the effects of D2 agonists in the present studies, it is conceivable that coupling of D1 and D2 receptors is necessary for DA to produce robust and consistent attenuation of non-NMDA receptor-mediated responses (Hu and White, 1994). Additional evidence has been obtained for electrophysiological alterations in D2 receptor function in nucleus accumbens in D1A mutants (Xu et al., 1994b). Clearly, more studies must be performed to examine and clarify this issue.

The present experiments support the findings that specific combinations of receptor subtype interactions lead to predictable responses. Based on our previous work (Cepeda et al., 1992b, 1993; Levine et al., 1996), activation of two combinations of EAA and DA receptor subtypes have very predictable outcomes. DA or the D1 agonist potentiate NMDA-mediated responses, whereas DA or the D2 agonist attenuate responses mediated by non-NMDA receptor activation. Other combinations do not lead to predictable outcomes. The present study examined the effects of DA or D1 receptor agonists on both NMDA and non-NMDA receptor-induced responses. D1 receptor activation had variable effects on responses induced by activation of non-NMDA receptors. In contrast, NMDA receptor-induced responses were potentiated consistently by DA or D1 receptor activation. A number of possibilities could account for highly predictable outcomes when NMDA and DA or D1 receptors are activated. A spatial or mechanistic coupling of these specific receptor subtypes may occur. NMDA and D1 receptor subtypes may be located in close proximity on the same spine, dendrite, or cell (Yung et al., 1995). Alternatively, D1 and NMDA receptors use the same transduction systems. Increasing cAMP enhances responses mediated by activation of NMDA receptors (Colwell and Levine, 1995), and D1 DA receptor activation increases cAMP (Stoof and Kebabian, 1981).

Basic electrophysiology and morphology

The present study showed that some basic electrophysiological and morphological properties of medium-size spiny neurons were not altered in the mutant. Except for the larger input resistance of cells in mutants bathed in Mg2+-free ACSF with CNQX, resting membrane potential, action potential parameters, input resistance, and basic measures of excitability were similar. Input resistance typically is attributed to K+ conductances. Without additional study of isolated conductances, it would be premature to speculate on the alterations underlying this increase in input resistance in the mutant cells bathed in Mg2+-free ACSF with CNQX. Few differences in the amplitudes, half-amplitude durations, and areas of responses in both standard ACSF and Mg2+-free ACSF containing CNQX were noted. There was a statistically significant increase in DPSP area in standard ACSF in mutants compared with controls. Because this response is primarily mediated by activation of non-NMDA receptors, it is possible that this receptor subtype has been altered in the mutant. Additional experiments will be necessary to examine this issue in more detail. No major differences in morphological parameters of the identified neurons were found. Most recordings were from medium-size spiny cells (Kawaguchi et al., 1989; Cepeda et al., 1992a, 1994); only one labeled cell was not a medium-size spiny neuron. However, the present analysis did not include detailed quantification. Subtle differences between medium-size neostriatal cells in mutants and controls may have been overlooked. We did not attempt to double label cells for neurotransmitters or receptors, or to determine their location with respect to patch or matrix compartments (Xu et al., 1994a).

Morphology, behavior, and electrophysiology in mutants

The present experiments provide additional molecular evidence validating the absence of D1A receptors in the mutant. Previously, in situ hybridization studies demonstrated that the mutant lacks message for the D1A receptor in the neostriatum (Drago et al., 1994). The findings obtained from the present reverse transcriptase experiments validate this outcome. The immunohistochemical demonstration that the neostriatum lacks D1A protein, however, is new and provides additional evidence for lack of receptor protein in the mutant. Previous studies of D1A DA receptor mutant mice have demonstrated a number of other morphological, electrophysiological, and behavioral alterations. Expression of dynorphin and substance P in the neostriatum is reduced (Drago et al., 1994; Xu et al., 1994a). Mutant mice are hyperactive, display decreased rearing, and do not respond behaviorally to D1 receptor agonists (Drago et al., 1994; Xu et al., 1994a,b). Cocaine, which produces hyperactivity in control mice, does not increase activity in mutants (Xu et al., 1994b; Miner et al., 1995). In extracellular electrophysiological studies, inhibitory effects of cocaine on nucleus accumbens neurons are reduced, and the inhibitory effects of D1 and D2 agonists are almost abolished (Xu et al., 1994b), suggesting that enabling interactions between D1 and D2 receptors are altered substantially (Hu and White, 1994).

Our results extend these findings and provide the first intracellular electrophysiological analysis of neostriatal neurons in this mutant strain. Neostriatal cells in mutants do not appear to be different from those in control mice. Neostriatal spiny neurons have similar gross morphological appearances in terms of somata, dendritic extent, and estimates of spine density. It is not surprising that these basic parameters are unaffected, because the mice survive and, unless challenged, appear similar to their littermates. When these animals are exposed to treatments that activate D1A receptors, then deficits appear.

Factors contributing to NMDA responses and DA modulation

The primary focus of this study was to determine whether DA-induced modulation was altered in the mutant. The present experiments were not designed to isolate the factors contributing to DA modulation of NMDA receptor-mediated responses in control and mutant mice. To provide validation, two complementary methods were used to evoke responses mediated by activation of NMDA receptors. In the first, NMDA was applied iontophoretically. This approach has the advantage of direct agonist application. However, surrounding neurons also are activated and may contribute to the response. We have demonstrated that DA and D1 agonists potentiate responses induced by NMDA receptor activation when activity of surrounding neurons was blocked by tetrodotoxin (Cepeda et al., 1995). Thus, it is unlikely that the surrounding cells added significantly to the effects of NMDA. The second approach used synaptic activation in Mg2+-free ACSF containing CNQX to evoke NMDA receptor activation. A disadvantage of this approach is that synaptic stimulation, although activating glutamatergic afferents, also activates local circuitry. We did not attempt to rule out contributions of GABA receptor activation or acetylcholine receptor activation in the present study. Previously, we have demonstrated that blockade of GABAA receptors has little influence on the modulatory actions of DA on EAA agonist-evoked responses (Levine et al., 1996). In addition, the cholinergic component appears to be minor when responses are evoked primarily by stimulation of afferents as described in the present study (Misgeld et al., 1980; Walsh et al., 1989; Cromwell et al., 1994).

Conclusions

The present studies provide evidence that the D1A receptor is necessary for DA to produce enhancement of responses mediated by activation of NMDA receptors. Furthermore, the findings support the idea that the effects of DA on responses mediated by non-NMDA receptors may require coupling or interactions between D1 and D2 receptor subtypes. Finally, these studies demonstrate that mutant mice provide a powerful tool for exploring ideas and testing hypotheses concerning the functional roles of DA receptor subtypes.

FOOTNOTES

Received May 6, 1996; revised June 24, 1996; accepted June 25, 1996.

  

This work was supported by U.S. Public Health Service Grants NS 35233, AG 10252, and HD05958 (M.S.L.) and NS 33277 (M.A.A.). J.D. is the recipient of a Basser Travelling Fellowship from the Royal Australasian College of Physicians and is supported by the Australian National Health and Medical Research Council. We thank Q. Yu for assistance in preparation of brain slices. We thank Abbott Pharmaceuticals for supplying the A-77636.

Correspondence should be addressed to Michael S. Levine, Mental Retardation Research Center, 760 Westwood Plaza, University of California, Los Angeles, Los Angeles, CA 90024-1759.


REFERENCES

  • Accili D, Fishbourne CS, Drago J, Steiner H, Lachowicz JE, Gerfen CR, Sibley DR, Westphal H, Fuchs S (1996) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93:1945-1949 . [Abstract/Free Full Text]
  • Acquas E, Day JC, Fibiger HC (1994) The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat. Eur J Pharmacol 260:85-87 . [Web of Science][Medline]
  • Altemus KL, Levine MS (1996) Potassium channel blockade does not alter the modulatory effects of dopamine in neostriatal slices. Brain Res 718:212-216. [Web of Science][Medline]
  • Ariano MA, Sibley DR (1994) Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes. Brain Res 649:95-110 . [Web of Science][Medline]
  • Balk J-H, Picetti R, Salardi A, Thirlet G, Dierich A, Depaulls A, LeMeur M, Borrelli E (1995) Parkinsonian-like locomotor impairments in mice lacking dopamine D2 receptors. Nature 377:424-428. [Medline]
  • Bouyer JJ, Park DH, Joh TH, Pickel VM (1984) Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res 302:267-275 . [Web of Science][Medline]
  • Carter-Russell HR, Song W-J, Surmeier DJ (1995) Coordinated expression of dopamine receptors (D1-D5) in single neostriatal neurons. Soc Neurosci Abstr 21:1425.
  • Cepeda C, Peacock W, Levine MS, Buchwald NA (1991a) Iontophoretic application of NMDA produces different types of excitatory responses in developing human cortical and caudate neurons. Neurosci Lett 126:167-171 . [Web of Science][Medline]
  • Cepeda C, Walsh JP, Buchwald NA, Levine MS (1991b) Neurophysiological maturation of cat caudate neurons: evidence from in vitro studies. Synapse 7:278-290 . [Web of Science][Medline]
  • Cepeda C, Lee N, Radisavljevic Z, Buchwald NA, Levine MS (1992a) Age-induced changes in electrophysiological responses of neostriatal neurons recorded in vitro. Neuroscience 51:411-423 . [Web of Science][Medline]
  • Cepeda C, Radisavljevic Z, Peacock W, Levine MS, Buchwald NA (1992b) Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex. Synapse 11:330-341 . [Web of Science][Medline]
  • Cepeda C, Buchwald NA, Levine MS (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci USA 90:9576-9580 . [Abstract/Free Full Text]
  • Cepeda C, Walsh JP, Peacock W, Buchwald NA, Levine MS (1994) Neurophysiological, pharmacological and morphological properties of human caudate neurons recorded in vitro. Neuroscience 59:89-103 . [Web of Science][Medline]
  • Cepeda C, Yu Q, Colwell CS, Buchwald NA, Levine MS (1995) NMDA-induced excitotoxicity in visually identified neostriatal neurons in slices. Modulation by dopamine. Soc Neurosci Abstr 21:912.
  • Cepeda C, Li Z, Levine MS (1996) Aging reduces neostriatal responsiveness to N-methyl-d-aspartate and dopamine; an in vitro electrophysiological study. Neuroscience 73:733-750. [Web of Science][Medline]
  • Cherubini E, Herrling PL, Lanfumey L, Stanzione PJ (1988) Excitatory amino acids in synaptic excitation of rat striatal neurones in vitro. J Physiol (Lond) 400:677-690 . [Abstract/Free Full Text]
  • Colwell CS, Levine MS (1995) Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms. J Neurosci 15:1704-1713 . [Abstract]
  • Cromwell HC, Buchwald NA, Levine MS (1994) Decortication alters locally evoked synaptic responses in the rat neostriatal slice. Soc Neurosci Abstr 20:563.
  • Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, Ooi GT, Grinberg A, Lee EJ, Huang SP, Bartlett PF, Jose PA, Sibley DR, Westphal H (1994) Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci USA 91:12564-12568 . [Abstract/Free Full Text]
  • Freund TF, Powell J, Smith AD (1984) Tyrosine hydroxylase immunoreactive boutons in synaptic contact with identified striatonigral neurons with particular reference to dendritic spines. Neuroscience 13:1189-1215 . [Web of Science][Medline]
  • Frey U, Huang Y-Y, Kandel ER (1993) Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260:1661-1664 . [Abstract/Free Full Text]
  • Herrling PL (1985) Pharmacology of the corticocaudate excitatory postsynaptic potentials in the cat: evidence for its mediation by quisqualate- or kainate-receptors. Neuroscience 14:417-426 . [Web of Science][Medline]
  • Herrling PL, Hull CD (1980) Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons. Brain Res 192:441-462 . [Web of Science][Medline]
  • Higashi H, Inanaga K, Nishi S, Uchimura N (1989) Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment. J Physiol (Lond) 408:587-603 . [Abstract/Free Full Text]
  • Horikawa K, Armstrong WE (1988) A versatile means of intracellular labeling, injection of biocytin and its detection with avidin conjugates. J Neurosci Methods 25:1-11 . [Web of Science][Medline]
  • Hu X-T, White F (1994) Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Synapse 17:43-61 . [Web of Science][Medline]
  • Huang Y-Y, Kandel ER (1995) D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc Natl Acad Sci USA 92:2446-2450 . [Abstract/Free Full Text]
  • Kawaguchi Y, Wilson CJ, Emson PC (1989) Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J Neurophysiol 62:1052-1068 . [Abstract/Free Full Text]
  • Kebabian JW, Britton DR, DeNinno MP, Perner R, Smith L, Jenner P, Schoenleber R, Williams M (1992) A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Eur J Pharmacol 229:203-209 . [Web of Science][Medline]
  • Knapp AG, Schmidt KF, Dowling JE (1990) Dopamine modulates the kinetics of ion channels gated by excitatory amino acids in retinal horizontal cells. Proc Natl Acad Sci USA 87:767-771 . [Abstract/Free Full Text]
  • Law-Tho D, Hirsch JC, Crepel F (1994) Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci Res 21:151-160 . [Web of Science][Medline]
  • Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865 . [Abstract/Free Full Text]
  • Levine MS, Cepeda C, Day M, Altemus KL, Li Z (1995) Dopaminergic modulation of responses evoked by activation of excitatory amino acid receptors in the neostriatum is dependent upon specific receptor subtypes. In: Cellular and molecular mechanisms of the striatum (Ariano, MA, Surmeier, DJ, eds) , p. 217. Georgetown, TX: Landes.
  • Levine MS, Li Z, Cepeda C, Cromwell HC, Altemus KL (1996) Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices. Synapse, in press.
  • Mercuri N, Bernardi G, Calabresi P, Cotugno A, Stanzione P (1985) Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms. Brain Res 358:110-121 . [Web of Science][Medline]
  • Miner LL, Drago J, Chamberlain PM, Donovan D, Uhl GR (1995) Retained cocaine conditioned place preference in D1 receptor deficient mice. NeuroReport 6:2314-2316. [Web of Science][Medline]
  • Misgeld U, Weiler MH, Bak IJ (1980) O) Intrinsic cholinergic excitation in the rat neostriatum: nicotinic and muscarinic receptors. Exp Brain Res 39:401-407 . [Web of Science][Medline]
  • Monsma FJ Jr, Mahan LC, McVittie LD, Gerfen CR, Sibley DR (1990) Molecular cloning and expression of a D1 dopamine receptor linked to adenylate cyclase activity. Proc Natl Acad Sci USA 87:6723-6727 . [Abstract/Free Full Text]
  • Nicola SM, Kombian SB, Malenka RC (1996) Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors. J Neurosci 16:1591-1604. [Abstract/Free Full Text]
  • Nisenbaum ES, Berger TW, Grace AA (1993) Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors. Synapse 14:221-242 . [Web of Science][Medline]
  • Noblett KL, Ariano MA (1996) Coexpression of receptor mRNA and protein: striatal dopamine and excitatory amino acid subtypes. J Neurosci Methods 66:61-67. [Web of Science][Medline]
  • Pennartz CM, Dolleman-Van der Weel MJ, Kitai ST, Lopes da Silva FH (1992) Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro. J Neurophysiol 67:1325-1334 . [Abstract/Free Full Text]
  • Pereda A, Nairn AC, Wolszon LR, Faber DS (1994) Postsynaptic modulation of synaptic efficacy at mixed synapses on the Mauthner cell. J Neurosci 14:3704-3712 . [Abstract]
  • Pereda A, Triller A, Korn H, Faber DS (1992) Dopamine enhances both electrotonic coupling and chemical excitatory postsynaptic potentials at mixed synapses. Proc Natl Acad Sci USA 89:12088-12092 . [Abstract/Free Full Text]
  • Seasack SR, Aoki C, Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106. [Abstract]
  • Smith AD, Bolam JP (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 13:259-265 . [Web of Science][Medline]
  • Smith DO, Lowe D, Temkin R, Jensen P, Hatt H (1995) Dopamine enhances glutamate-activated currents in spinal motoneurons. J Neurosci 15:3905-3912 . [Abstract]
  • Stoof JC, Kebabian JW (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366-368 . [Medline]
  • Walsh JP, Hull CD, Levine MS, Buchwald NA (1989) Kynurenic acid antagonizes the excitatory post-synaptic potential elicited in neostriatal neurons in the in vitro slice of the rat. Brain Res 480:290-293 . [Web of Science][Medline]
  • Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S (1994a) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742 . [Web of Science][Medline]
  • Xu M, Hu X-T, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S (1994b) Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1A receptor mutant mice. Cell 79:945-955 . [Web of Science][Medline]
  • Xu M, Caine SB, Cooper DC, Gold AM, Graybiel AM, Hu X-T, Koeltzow TE, Koob G, Moratalla R, White FJ, Tonegawa S (1995) Analysis of dopamine D3 and D1 receptor mutant mice. Soc Neurosci Abstr 21:363.
  • Yung KKL, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-730. [Web of Science][Medline]
Copyright ©1996 Society for Neuroscience   0270-6474/1996/165870-13$05.00/0



This article has been cited by other articles:


Home page
 J. Physiol.Home page
N. P. Lapointe, P. Rouleau, R.-V. Ung, and P. A. Guertin
Specific role of dopamine D1 receptors in spinal network activation and rhythmic movement induction in vertebrates
J. Physiol., April 1, 2009; 587(7): 1499 - 1511.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. H. Tran, T. Uwano, T. Kimura, E. Hori, M. Katsuki, H. Nishijo, and T. Ono
Dopamine D1 Receptor Modulates Hippocampal Representation Plasticity to Spatial Novelty
J. Neurosci., December 10, 2008; 28(50): 13390 - 13400.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
H. Tong and A. J. Gibb
Dopamine D1 receptor inhibition of NMDA receptor currents mediated by tyrosine kinase-dependent receptor trafficking in neonatal rat striatum
J. Physiol., October 1, 2008; 586(19): 4693 - 4707.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T.-S. Tang, X. Chen, J. Liu, and I. Bezprozvanny
Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's Disease
J. Neurosci., July 25, 2007; 27(30): 7899 - 7910.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
N. Wu, C. Cepeda, X. Zhuang, and M. S. Levine
Altered Corticostriatal Neurotransmission and Modulation in Dopamine Transporter Knock-Down Mice
J Neurophysiol, July 1, 2007; 98(1): 423 - 432.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. J. Hallett, R. Spoelgen, B. T. Hyman, D. G. Standaert, and A. W. Dunah
Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking.
J. Neurosci., April 26, 2006; 26(17): 4690 - 4700.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
C. R. Yang and L. Chen
Targeting Prefrontal Cortical Dopamine D1 and N-Methyl-D-Aspartate Receptor Interactions in Schizophrenia Treatment
Neuroscientist, October 1, 2005; 11(5): 452 - 470.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. H. Tran, R. Tamura, T. Uwano, T. Kobayashi, M. Katsuki, and T. Ono
Dopamine D1 receptors involved in locomotor activity and accumbens neural responses to prediction of reward associated with place
PNAS, February 8, 2005; 102(6): 2117 - 2122.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T.-S. Tang and I. Bezprozvanny
Dopamine Receptor-mediated Ca2+ Signaling in Striatal Medium Spiny Neurons
J. Biol. Chem., October 1, 2004; 279(40): 42082 - 42094.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Chergui, P. Svenningsson, and P. Greengard
Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum
PNAS, February 17, 2004; 101(7): 2191 - 2196.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S.-P. Onn, A. A. Fienberg, and A. A. Grace
Dopamine Modulation of Membrane Excitability in Striatal Spiny Neurons is Altered in DARPP-32 Knockout Mice
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 870 - 879.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Fiorentini, F. Gardoni, P. Spano, M. Di Luca, and C. Missale
Regulation of Dopamine D1 Receptor Trafficking and Desensitization by Oligomerization with Glutamate N-Methyl-D-aspartate Receptors
J. Biol. Chem., May 23, 2003; 278(22): 20196 - 20202.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. Gonzalez-Islas and J. J. Hablitz
Dopamine Enhances EPSCs in Layer II-III Pyramidal Neurons in Rat Prefrontal Cortex
J. Neurosci., February 1, 2003; 23(3): 867 - 875.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
J. Flores-Hernandez, C. Cepeda, E. Hernandez-Echeagaray, C. R. Calvert, E. S. Jokel, A. A. Fienberg, P. Greengard, and M. S. Levine
Dopamine Enhancement of NMDA Currents in Dissociated Medium-Sized Striatal Neurons: Role of D1 Receptors and DARPP-32
J Neurophysiol, December 1, 2002; 88(6): 3010 - 3020.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
O.-J. Kim, M. A. Ariano, R. A. Lazzarini, M. S. Levine, and D. R. Sibley
Neurofilament-M Interacts with the D1 Dopamine Receptor to Regulate Cell Surface Expression and Desensitization
J. Neurosci., July 15, 2002; 22(14): 5920 - 5930.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
S. Yasumoto, E. Tanaka, G. Hattori, H. Maeda, and H. Higashi
Direct and Indirect Actions of Dopamine on the Membrane Potential in Medium Spiny Neurons of the Mouse Neostriatum
J Neurophysiol, March 1, 2002; 87(3): 1234 - 1243.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
J. Wang and P. O'Donnell
D1 Dopamine Receptors Potentiate NMDA-mediated Excitability Increase in Layer V Prefrontal Cortical Pyramidal Neurons
Cereb Cortex, May 1, 2001; 11(5): 452 - 462.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
C. Cepeda, R. S. Hurst, K. L. Altemus, J. Flores-Hernandez, C. R. Calvert, E. S. Jokel, D. K. Grandy, M. J. Low, M. Rubinstein, M. A. Ariano, et al.
Facilitated Glutamatergic Transmission in the Striatum of D2 Dopamine Receptor-Deficient Mice
J Neurophysiol, February 1, 2001; 85(2): 659 - 670.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. K. Seamans, D. Durstewitz, B. R. Christie, C. F. Stevens, and T. J. Sejnowski
Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons
PNAS, December 22, 2000; (2000) 11518798.
[Abstract] [Full Text]

Home page
 Cereb CortexHome page
B. L. Lewis and P. O'Donnell
Ventral Tegmental Area Afferents to the Prefrontal Cortex Maintain Membrane Potential 'Up' States in Pyramidal Neurons via D1 Dopamine Receptors
Cereb Cortex, December 1, 2000; 10(12): 1168 - 1175.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. L. Smith-Roe and A. E. Kelley
Coincident Activation of NMDA and Dopamine D1 Receptors within the Nucleus Accumbens Core Is Required for Appetitive Instrumental Learning
J. Neurosci., October 15, 2000; 20(20): 7737 - 7742.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A. A. Fienberg, N. Hiroi, P. G. Mermelstein, W. Song, G. L. Snyder, A. Nishi, A. Cheramy, J. P. O'Callaghan, D. B. Miller, D. G. Cole, et al.
DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission
Science, August 7, 1998; 281(5378): 838 - 842.
[Abstract] [Full Text]

Home page
 J. Neurophysiol.Home page
S. M. Nicola and R. C. Malenka
Modulation of Synaptic Transmission by Dopamine and Norepinephrine in Ventral but not Dorsal Striatum
J Neurophysiol, April 1, 1998; 79(4): 1768 - 1776.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
C. Cepeda, C. S. Colwell, J. N. Itri, S. H. Chandler, and M. S. Levine
Dopaminergic Modulation of NMDA-Induced Whole Cell Currents in Neostriatal Neurons in Slices: Contribution of Calcium Conductances
J Neurophysiol, January 1, 1998; 79(1): 82 - 94.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
F. Gonon
Prolonged and Extrasynaptic Excitatory Action of Dopamine Mediated by D1 Receptors in the Rat Striatum In Vivo
J. Neurosci., August 1, 1997; 17(15): 5972 - 5978.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Harvey and M. G. Lacey
A Postsynaptic Interaction between Dopamine D1 and NMDA Receptors Promotes Presynaptic Inhibition in the Rat Nucleus Accumbens via Adenosine Release
J. Neurosci., July 15, 1997; 17(14): 5271 - 5280.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. A. Otmakhova and J. E. Lisman
D1/D5 Dopamine Receptor Activation Increases the Magnitude of Early Long-Term Potentiation at CA1 Hippocampal Synapses
J. Neurosci., December 1, 1996; 16(23): 7478 - 7486.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. K. Seamans, D. Durstewitz, B. R. Christie, C. F. Stevens, and T. J. Sejnowski
Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons
PNAS, January 2, 2001; 98(1): 301 - 306.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (97)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levine, M. S.
Right arrow Articles by Westphal, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levine, M. S.
Right arrow Articles by Westphal, H.

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-